XML 54 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share - Schedule of Diluted Loss Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Numerator        
Net loss attributed to Inovio Pharmaceuticals, Inc $ (34,134,570) $ (20,759,338) $ (66,699,593) $ (47,506,869)
Adjustment for decrease in fair value of warrant liability (423,296) (2,841) (227,273) 0
Numerator for use in diluted net loss per share $ (34,557,866) $ (20,762,179) $ (66,926,866) $ (47,506,869)
Denominator        
Weighted average number of common shares outstanding (in shares) 86,952,024 73,602,834 78,894,881 72,932,199
Effect of dilutive potential common shares (in shares) 138,659 186,174 148,599 0
Denominator for use in diluted net loss per share (in shares) 87,090,683 73,789,008 79,043,480 72,932,199
Net loss per share, diluted (in dollars per share) $ (0.40) $ (0.28) $ (0.85) $ (0.65)